An estimated 108 million people in India suffer from endocrine and metabolic disorders. Diabetes is the most prevalent disease in this therapeutic area with approximately 35.5 million cases. It is estimated that by 2030 there will be approximately 80 million cases of Diabetes in India, which is almost twice as many as China which is projected to have approximately 43 million cases. Other common diseases and disorders seen are thyroid, reproductive/infertility, obesity, lipid disorders and growth disorders.

Our clinical investigators have experience conducting global trials and have access to a large and diverse treatment naive patient pool. In fact, these investigators see 400 – 500 new cases per month and provide treatment for approximately 2,000 ongoing cases per month. Some of their fields of expertise are diabetes, thyroid disorder, obesity and lipid disorders. Their research has been published in some of the countries top medical journals including the National Medical Journal of India, Post Graduate Medical Journal and Journal of Association of Physicians of India (JAPI).